Braga Barbara Leitao, da Cunha Scalco Renata, Homma Thais Kataoka, Freire Bruna Lucheze, Cellin Laurana De Polli, Canton Ana Pinheiro Machado, Lerario Antônio Marcondes, de Assis Funari Mariana Ferreira, de Souza Vinicius, Bertola Debora Romeo, Malaquias Alexsandra Christianne, Mendonca Berenice Bilharinho, de Lima Jorge Alexander Augusto
Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular (LIM42), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Unidade de Endocrinologia Genética (LIM25), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Clin Genet. 2025 Apr;107(4):441-445. doi: 10.1111/cge.14659. Epub 2024 Nov 25.
Silver-Russell syndrome (SRS) is an imprinting disorder mainly characterized by pre- and postnatal growth restriction. Most SRS cases are due to 11p15.5 loss of methylation (11p15.5 LOM) or maternal uniparental disomy of chromosome 7 [UPD(7)mat], but several patients remain molecularly undiagnosed. This study describes the molecular investigation of children with a clinical diagnosis or suspicion of SRS at a tertiary center specialized in growth disorders. Thirty-nine patients were evaluated with multiplex ligation-dependent probe amplification, chromosomal microarray and/or massively parallel sequencing. The most common result was 11p15.5 LOM (n = 17; 43.5%), followed by UPD(7)mat (n = 2; 5.1%). Additionally, we found maternal duplications of the imprinting centers in 11p15.5 (n = 2; 5.1%), and genetic defects in SRS-causing genes (IGF2 and HMGA2) (n = 3; 7.7%; two mutations and one deletion). Alternative molecular diagnoses included UPD(14)mat (n = 1; 2,6%), UPD(20)mat (n = 1;2,6%), copy number variants (n = 2; 5.1%), and mutations in genes associated with other growth disorders (n = 4; 10.3%), leading to diagnoses of Temple syndrome, Mulchandani-Bhoj-Conlin syndrome, IGF-1 resistance (IGF1R), Bloom syndrome (BLM), Gabriele-De Vries syndrome (YY1), Intellectual developmental disorder autosomal dominant 50 with behavioral abnormalities (NAA15), and Intellectual developmental disorder 64 (ZNF292). These findings underscore the importance of establishing the molecular diagnosis of SRS and its differential diagnoses to guide appropriate management and genetic counseling.
Silver-Russell综合征(SRS)是一种印记障碍,主要特征为出生前和出生后的生长受限。大多数SRS病例是由于11p15.5甲基化缺失(11p15.5 LOM)或7号染色体母源单亲二倍体[UPD(7)mat],但仍有若干患者在分子层面未得到诊断。本研究描述了在一家专门诊治生长障碍的三级中心,对临床诊断或疑似SRS的儿童进行的分子研究。39例患者接受了多重连接依赖探针扩增、染色体微阵列和/或大规模平行测序评估。最常见的结果是11p15.5 LOM(n = 17;43.5%),其次是UPD(7)mat(n = 2;5.1%)。此外,我们发现11p15.5印记中心的母源重复(n = 2;5.1%)以及SRS致病基因(IGF2和HMGA2)的遗传缺陷(n = 3;7.7%;两个突变和一个缺失)。其他分子诊断包括UPD(14)mat(n = 1;2.6%)、UPD(20)mat(n = 1;2.6%)、拷贝数变异(n = 2;5.1%)以及与其他生长障碍相关基因的突变(n = 4;10.3%),从而诊断出坦普尔综合征、穆尔钱达尼-博杰-康林综合征、IGF-1抵抗(IGF1R)、布卢姆综合征(BLM)、加布里埃莱-德弗里斯综合征(YY1)、伴有行为异常的常染色体显性智力发育障碍50(NAA15)以及智力发育障碍64(ZNF292)。这些发现强调了确立SRS分子诊断及其鉴别诊断对于指导恰当管理和遗传咨询的重要性。